85 related articles for article (PubMed ID: 12091196)
1. Expression of Oct-6, a POU III domain transcription factor, in schizophrenia.
Ilia M; Beasley C; Meijer D; Kerwin R; Cotter D; Everall I; Price J
Am J Psychiatry; 2002 Jul; 159(7):1174-82. PubMed ID: 12091196
[TBL] [Abstract][Full Text] [Related]
2. Expression of POU-domain transcription factor, Oct-6, in schizophrenia, bipolar disorder and major depression.
Ubhi K; Price J
BMC Psychiatry; 2005 Oct; 5():38. PubMed ID: 16246257
[TBL] [Abstract][Full Text] [Related]
3. Alteration in estrogen receptor alpha mRNA levels in frontal cortex and hippocampus of patients with major mental illness.
Perlman WR; Tomaskovic-Crook E; Montague DM; Webster MJ; Rubinow DR; Kleinman JE; Weickert CS
Biol Psychiatry; 2005 Nov; 58(10):812-24. PubMed ID: 16112656
[TBL] [Abstract][Full Text] [Related]
4. Immunohistochemical localization of GABAB receptor in the entorhinal cortex and inferior temporal cortex of schizophrenic brain.
Mizukami K; Ishikawa M; Hidaka S; Iwakiri M; Sasaki M; Iritani S
Prog Neuropsychopharmacol Biol Psychiatry; 2002 Feb; 26(2):393-6. PubMed ID: 11817519
[TBL] [Abstract][Full Text] [Related]
5. The NR1 N-methyl-D-aspartate subunit and brain-derived neurotrophic factor in temporal lobe epilepsy hippocampus: a comparison of patients with and without coexisting psychiatric symptoms.
Toro CT; Hallak JE; Dunham JS; Leite JP; Sakamoto AC; Guarnieri R; Fong V; Deakin JF
Epilepsia; 2007 Dec; 48(12):2352-6. PubMed ID: 17919302
[TBL] [Abstract][Full Text] [Related]
6. Low GSK-3beta immunoreactivity in postmortem frontal cortex of schizophrenic patients.
Kozlovsky N; Belmaker RH; Agam G
Am J Psychiatry; 2000 May; 157(5):831-3. PubMed ID: 10784483
[TBL] [Abstract][Full Text] [Related]
7. Decreased expression of the embryonic form of the neural cell adhesion molecule in schizophrenic brains.
Barbeau D; Liang JJ; Robitalille Y; Quirion R; Srivastava LK
Proc Natl Acad Sci U S A; 1995 Mar; 92(7):2785-9. PubMed ID: 7708724
[TBL] [Abstract][Full Text] [Related]
8. Expression of the POU domain transcription factor, Oct-6, is attenuated in the adult mouse telencephalon, but increased by neurotoxic damage.
Ilia M; Bazigou E; Price J
Exp Neurol; 2003 Jun; 181(2):159-69. PubMed ID: 12781989
[TBL] [Abstract][Full Text] [Related]
9. Gender and age related expression of Oct-6--a POU III domain transcription factor, in the adult mouse brain.
Ilia M; Sugiyama Y; Price J
Neurosci Lett; 2003 Jun; 344(2):138-40. PubMed ID: 12782346
[TBL] [Abstract][Full Text] [Related]
10. Evidence of altered calmodulin immunoreactivity in areas 9 and 32 of schizophrenic prefrontal cortex.
Broadbelt K; Jones LB
J Psychiatr Res; 2008 Jul; 42(8):612-21. PubMed ID: 18289558
[TBL] [Abstract][Full Text] [Related]
11. Cholecystokinin messenger RNA deficit in frontal and temporal cerebral cortex in schizophrenia.
Virgo L; Humphries C; Mortimer A; Barnes T; Hirsch S; de Belleroche J
Biol Psychiatry; 1995 May; 37(10):694-701. PubMed ID: 7640324
[TBL] [Abstract][Full Text] [Related]
12. Disrupted pattern of D2 dopamine receptors in the temporal lobe in schizophrenia. A postmortem study.
Goldsmith SK; Shapiro RM; Joyce JN
Arch Gen Psychiatry; 1997 Jul; 54(7):649-58. PubMed ID: 9236549
[TBL] [Abstract][Full Text] [Related]
13. Oct-6 transcription factor.
Ilia M
Int Rev Neurobiol; 2004; 59():471-89. PubMed ID: 15006499
[TBL] [Abstract][Full Text] [Related]
14. GABABR1 receptor protein expression in human mesial temporal cortex: changes in temporal lobe epilepsy.
Muñoz A; Arellano JI; DeFelipe J
J Comp Neurol; 2002 Jul; 449(2):166-79. PubMed ID: 12115687
[TBL] [Abstract][Full Text] [Related]
15. Decreased synaptophysin in the medial temporal lobe in schizophrenia demonstrated using immunoautoradiography.
Eastwood SL; Harrison PJ
Neuroscience; 1995 Nov; 69(2):339-43. PubMed ID: 8552231
[TBL] [Abstract][Full Text] [Related]
16. [Clinical and neuropsychological correlates of proton magnetic resonance spectroscopy detected metabolites in brains of first-episode and schizophrenic patients].
Szulc A; Galińska B; Tarasów E; Walecki J; Dzienis W; Kubas B; Czernikiewicz A
Psychiatr Pol; 2003; 37(6):977-88. PubMed ID: 14727370
[TBL] [Abstract][Full Text] [Related]
17. Serotonin uptake sites and serotonin receptors are altered in the limbic system of schizophrenics.
Joyce JN; Shane A; Lexow N; Winokur A; Casanova MF; Kleinman JE
Neuropsychopharmacology; 1993 Jun; 8(4):315-36. PubMed ID: 8512620
[TBL] [Abstract][Full Text] [Related]
18. N-acetylaspartate and N-Acetylaspartylglutamate deficits in superior temporal cortex in schizophrenia and bipolar disorder: a postmortem study.
Nudmamud S; Reynolds LM; Reynolds GP
Biol Psychiatry; 2003 Jun; 53(12):1138-41. PubMed ID: 12814865
[TBL] [Abstract][Full Text] [Related]
19. Growth-associated protein 43 (GAP-43) and synaptophysin alterations in the dentate gyrus of patients with schizophrenia.
Chambers JS; Thomas D; Saland L; Neve RL; Perrone-Bizzozero NI
Prog Neuropsychopharmacol Biol Psychiatry; 2005 Feb; 29(2):283-90. PubMed ID: 15694236
[TBL] [Abstract][Full Text] [Related]
20. The neuropathological study of myelin oligodendrocyte glycoprotein in the temporal lobe of schizophrenia patients.
Marui T; Torii Y; Iritani S; Sekiguchi H; Habuchi C; Fujishiro H; Oshima K; Niizato K; Hayashida S; Masaki K; Kira J; Ozaki N
Acta Neuropsychiatr; 2018 Aug; 30(4):232-240. PubMed ID: 29564992
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
